5-(4-Methoxy-phenyl)-7-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamine

ID: ALA176705

PubChem CID: 354479

Max Phase: Preclinical

Molecular Formula: C19H16N4O

Molecular Weight: 316.36

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)cc1

Standard InChI:  InChI=1S/C19H16N4O/c1-24-15-9-7-13(8-10-15)16-11-23(14-5-3-2-4-6-14)19-17(16)18(20)21-12-22-19/h2-12H,1H3,(H2,20,21,22)

Standard InChI Key:  KOFGCEDKGQUYDQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
    2.1409   -8.3682    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1396   -9.1948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8517   -9.6073    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8497   -7.9559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5670   -8.3642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5675   -9.1948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3577   -9.4510    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8455   -8.7786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3568   -8.1071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6084   -7.3262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4157   -7.1555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6698   -6.3724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1178   -5.7595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3083   -5.9348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0578   -6.7176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6117  -10.2297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0589  -10.8423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3134  -11.6252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1204  -11.7967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6722  -11.1790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4147  -10.3985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8458   -7.1319    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3709   -4.9754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1765   -4.8024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11 12  1  0
  2  3  1  0
 12 13  2  0
  3  6  2  0
 13 14  1  0
  1  2  2  0
 14 15  2  0
 15 10  1  0
  9 10  1  0
  5  4  2  0
  6  7  1  0
 16 17  2  0
  7  8  1  0
 17 18  1  0
  8  9  2  0
 18 19  2  0
  9  5  1  0
 19 20  1  0
  4  1  1  0
 20 21  2  0
 21 16  1  0
  7 16  1  0
  5  6  1  0
  4 22  1  0
 10 11  2  0
 13 23  1  0
 23 24  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA176705

   5-(4-methoxyphenyl)-7-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 316.36

Molecular Weight (Monoisotopic): 316.1324

AlogP: 3.68

#Rotatable Bonds: 3

Polar Surface Area: 65.96

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 5.80

CX LogP: 3.65

CX LogD: 3.64

Aromatic Rings: 4

Heavy Atoms: 24

QED Weighted: 0.63

Np Likeness Score: -0.85

References

1. Missbach M, Altmann E, Widler L, Susa M, Buchdunger E, Mett H, Meyer T, Green J..  (2000)  Substituted 5,7-diphenyl-pyrrolo[2,3d]pyrimidines: potent inhibitors of the tyrosine kinase c-Src.,  10  (9): [PMID:10853665] [10.1016/s0960-894x(00)00131-1]

2. Tintori C, Magnani M, Schenone S, Botta M..  (2009)  Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors.,  44  (3): [PMID:18722033] [10.1016/j.ejmech.2008.07.002]

3. Shahlaei M, Pourhossein A.  (2013)  A 2D image-based method for modeling some c-Src tyrosine kinase inhibitors,  22  (6): [10.1007/s00044-012-0308-3]

Source

Source(1):

• Scientific Literature